Aurora kinase B inhibitor AZD1152: repurposing for treatment of lupus nephritis driven by the results of clinical trials.

7 f and g) and slightly decreased CD8 + Ki67 + T cells, though the latter did not reach statistical significance ( Fig. 7 h).

also in 111,027 other papers

While the MT-treated group exhibited a decreasing trend in splenocyte numbers, this change was not statistically significant ( Fig. 2 e).

also in 47,180 other papers